WHO backs use of GLP-1 therapies for obesity, warns access will remain limited

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally ...
Capital FM

WHO issues first global guideline on using GLP-1 medicines to treat obesity

Obesity remains a pressing global health challenge and was linked to 3.7 million deaths in 2024. - Kenya breaking news | Kenya news today | Capitalfm.co.ke ...
The American Journal of Managed Care

WHO Publishes GLP-1 Guidelines for Obesity Treatment

Amid soaring global demand for glucagon-like peptide-1 (GLP-1) medications and widespread concerns about affordability and access, the World Health Organization (WHO) released its global comprehensive ...

WHO calls for 'responsible use' of GLP-1 drugs for long term obesity care

The guideline reframes obesity as a chronic disease needing lifelong care, recommending GLP-1 therapies with behavioural ...